Immunogenicity of a trivalent influenza vaccine and persistence of induced immunity in adults aged ≥60 years in Taizhou City, Zhejiang Province, China, during the 2018–2019 season
Yearly administration of influenza vaccine with recommendations can help control seasonal influenza epidemics in adults aged ≥60 years. Here, we describe the results of a prospective study observing the immunogenicity and persistence of induced immunity of a trivalent inactivated split-virion influe...
Main Authors: | Yuting Liao, Yan Jin, Hangjie Zhang, Juan Yang, Jian Fu, Huakun Lv |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2022-11-01
|
Series: | Human Vaccines & Immunotherapeutics |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/21645515.2022.2071061 |
Similar Items
-
Immunogenicity of trivalent seasonal influenza vaccine in patients with chronic obstructive pulmonary disease
by: Yan Li, et al.
Published: (2021-09-01) -
A phase 2/3 double-blind, randomized, placebo-controlled study to evaluate the safety and immunogenicity of a seasonal trivalent inactivated split-virion influenza vaccine (IVACFLU-S) in healthy adults in Vietnam
by: Phan Trong Lan, et al.
Published: (2019-12-01) -
Immunogenicity and safety of a trivalent inactivated influenza vaccine produced in Shenzhen, China
by: Zhaojun Mo, et al.
Published: (2017-06-01) -
Immunogenicity and safety of a trivalent inactivated influenza vaccine produced in Shenzhen, China versus a comparator influenza vaccine: a phase IV randomized study
by: Yuemei Hu, et al.
Published: (2019-05-01) -
Immunogenicity and safety of seasonal influenza vaccines in children under 3 years of age
by: Tia Aoun, et al.
Published: (2023-12-01)